SBFM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Sunshine Biopharma Inc (SBFM) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available. The stock lacks positive momentum, has weak financial performance, and no significant catalysts to drive growth in the near term. Holding off on investment is recommended until stronger signals or catalysts emerge.
The technical indicators are mixed to bearish. The MACD is slightly positive but contracting, RSI is neutral at 39.179, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 0.998, with key support at 0.964 and resistance at 1.031.
Hedge funds are significantly increasing their buying activity, up 11812.88% over the last quarter, which could indicate institutional interest.
The company's financial performance in Q4 2025 shows a decline in revenue (-10.61% YoY), net income (-0.80% YoY), and EPS (-56.00% YoY). Additionally, there is no recent news, no congress trading data, and no significant insider activity to suggest a positive near-term catalyst.
In Q4 2025, Sunshine Biopharma Inc reported declining revenue (-10.61% YoY), net income (-0.80% YoY), and EPS (-56.00% YoY). However, gross margin improved by 8.27% YoY to 34.16%, which is a slight positive.
No analyst rating or price target changes are provided. Wall Street sentiment is unclear for this stock.
